General Information of the Compound
| Compound ID |
CP0570958
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[2-(4-aminobutylamino)-6-[4-(4-benzylpiperazin-1-yl)anilino]purin-9-yl]cyclopentan-1-ol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H41N9O
|
||||||||||||||||||
| Molecular Weight |
555.731
|
||||||||||||||||||
| Canonical SMILES |
NCCCCNc1nc(Nc2ccc(cc2)N2CCN(Cc3ccccc3)CC2)c2ncn(C3CCC(O)C3)c2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H41N9O/c32-14-4-5-15-33-31-36-29(28-30(37-31)40(22-34-28)26-12-13-27(41)20-26)35-24-8-10-25(11-9-24)39-18-16-38(17-19-39)21-23-6-2-1-3-7-23/h1-3,6-11,22,26-27,41H,4-5,12-21,32H2,(H2,33,35,36,37)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WKOLAIGTJCOHRL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01092, Platelet-derived growth factor receptor alpha
Cell Viability or Cytotoxicity Assay